TPM3 and cancer: Most functional NTRK fusion proteins lack the extracellular ligand-combining domain of Trk; instead, the partner gene is expressed in a homogenous dimer, which induces ligand-independent activation of the tyrosine kinase domain and upregulates downstream cancer-associated pathways.